WELCOME TO SALDA

The Southern African Laboratory Diagnostics Association is a body that represents laboratory medicine in Southern Africa and is a unified voice around IVD’s and a collaboration of multinational and local companies who distribute,supply and manufacture In Vitro Diagnostic tests. IVDs contribute to more than 70% of all medical diagnosis and can be used to decrease overall healthcare costs. We believe that broader access to innovative diagnostic tools will drive and support the healthcare paradigm. Our association aims to lead and highlight the relevance and impact of IVD, influence patient lives and wellbeing, improve access, and  propel the market within Southern Africa. We actively engage with necessary stakeholders, public, private, advocacy, patient groups about the value industry brings to patients.

Latest Industry News

09OCT

Rwanda launched a vaccine trial against the Marburg virus


Rwanda launched a vaccine trial against the Marburg virus on Sunday in desperate efforts to combat an outbreak
15SEP

WHO Prequalifies a Mpox Vaccine, Clearing Path to Access


The World Health Organization (WHO) recently announced the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list. According to WHO, the prequalification approval is expected to facilitate timely and increased access to this vital product in communities with urgent need.
[READ MORE]
14AUG

The Africa Centers for Disease Control and Prevention (Africa CDC) declared a public health emergency in response to a rapidly escalating MPox outbreak across Africa.


The Africa Centers for Disease Control and Prevention (Africa CDC) declared a public health emergency in response to a rapidly escalating MPox outbreak across Africa. The declaration aims to improve coordination and efficiency of the response, address the limited diagnostic capabilities, and ensure equitable distribution of the currently limited vaccine supply.
[READ MORE]
15SEP

WHO Prequalifies a Mpox Vaccine, Clearing Path to Access


The World Health Organization (WHO) recently announced the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list. According to WHO, the prequalification approval is expected to facilitate timely and increased access to this vital product in communities with urgent need.